| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/09/2005 | WO2005034890A3 Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides |
| 06/09/2005 | WO2005034854A3 Water dispersible film |
| 06/09/2005 | WO2005033279A3 Discovery of novel soluble crystalline anesthetics |
| 06/09/2005 | WO2005033112A3 Substituted indole derivatives |
| 06/09/2005 | WO2005028475A3 Compositions useful as inhibitors of protein kinases |
| 06/09/2005 | WO2005025500A3 Process for preparing water soluble diterpenes and their applications |
| 06/09/2005 | WO2005021095A3 Treatment of stuttering and other communication disorders with norepinephrine reuptake inhibitors |
| 06/09/2005 | WO2005021003A3 Immunosuppressive effects of pteridine derivatives |
| 06/09/2005 | WO2005020914A3 Pyridomorphinans, pyridazinomorphinans and use thereof |
| 06/09/2005 | WO2005020910A3 Cyclooxygenase-2 selective inhibitor and corticotropin releasing factor antagonist compositions for treating ischemic mediated cns disorders or injuries |
| 06/09/2005 | WO2005020876A3 Pharmaceutical composition, method of manufacturing and therapeutic use thereof |
| 06/09/2005 | WO2005018564A3 Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage |
| 06/09/2005 | WO2005018544A3 Therapy-enhancing glucan |
| 06/09/2005 | WO2005016893A3 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 06/09/2005 | WO2005016286A3 Pyrazine modulators of cannabinoid receptors |
| 06/09/2005 | WO2005016261A3 Aripiprazole and haloperidol pamoate salts |
| 06/09/2005 | WO2005013996A3 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents |
| 06/09/2005 | WO2005013903A3 Derivatives of substituted quinone and uses thereof |
| 06/09/2005 | WO2005012276A3 Intermediate products of the synthesis of fluorized inhibitors of aspartic proteases |
| 06/09/2005 | WO2005011609A3 Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| 06/09/2005 | WO2005011608A3 PHARMACEUTICAL COMPOSITION COMPRISING A NON-GLUCOCORTICOID STEROID AND A cAMP INHIBITOR |
| 06/09/2005 | WO2005011579A3 Treatment of dependence withdrawal |
| 06/09/2005 | WO2005009434A3 Compounds and methods for inducing apoptosis in cancer cells |
| 06/09/2005 | WO2005007092A3 Novel chemical compounds |
| 06/09/2005 | WO2005004891A3 Use of an antioxidant in a dermatological and/or cosmetic composition |
| 06/09/2005 | WO2005000248A3 Compositions and methods for skin conditioning |
| 06/09/2005 | WO2005000227A3 Methods of treating tnf-mediated disorders |
| 06/09/2005 | WO2004105737A3 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents |
| 06/09/2005 | WO2004096137A3 Annatto extract compositions, including geranyl geraniols and methods of use |
| 06/09/2005 | WO2004094020A3 Crystal growth devices and systems, and methods for using same |
| 06/09/2005 | WO2004080410A3 Furanose-type bicyclic carbohydrates with biological activity |
| 06/09/2005 | WO2004077938A3 Novel chemical entities and methods for their use in treatment of metabolic disorders |
| 06/09/2005 | WO2004062623A3 Method of treating functional bowel disorders |
| 06/09/2005 | WO2004052845A8 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
| 06/09/2005 | WO2004041118A8 Therapeutic compositions for drug delivery to and through covering epithelia |
| 06/09/2005 | WO2004012671A3 Substituted furo [2,3-b] pyridine derivatives |
| 06/09/2005 | WO2003088897A3 Fab i inhibitors |
| 06/09/2005 | WO2003072023A3 Novel compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer |
| 06/09/2005 | US20050125044 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| 06/09/2005 | US20050125039 Treatment of hepatitis C using hyperthermia |
| 06/09/2005 | US20050124965 Container containing blood and sprotease inhbitor tabilizer; prevent protein degradation |
| 06/09/2005 | US20050124963 Method for treating aspects of alcoholism, addiction and psychosis |
| 06/09/2005 | US20050124862 Thyroid hormone analogs and methods of use |
| 06/09/2005 | US20050124817 Method for the preparation of citalopram |
| 06/09/2005 | US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
| 06/09/2005 | US20050124789 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/09/2005 | US20050124787 Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 06/09/2005 | US20050124703 Polycosanols from Ericerus pela wax |
| 06/09/2005 | US20050124702 Using tricine; antiseptic for contact lenses; artificial tears |
| 06/09/2005 | US20050124701 Complex containing amantadine, memantine, rimantadine; central nervous system disorders; brain disorders ; strokes; Alzheimer's disease; Parkinson's disease; antiepileptic agents; metabolism disorders; vision defects; neuropathin pain |
| 06/09/2005 | US20050124700 uses the strong antimicrobial properties of polymeric biguanides and the low cytotoxicity profile of polymeric quaternary ammonium compounds |
| 06/09/2005 | US20050124699 Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells |
| 06/09/2005 | US20050124698 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 06/09/2005 | US20050124697 Topical applying to skins; sunscreen agents; anticancer agents; using arylpropionic acid |
| 06/09/2005 | US20050124696 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124695 Induction variations in central nervous system of rodents by administering kainate receptors antagonist to infant ; drug design, drug screening |
| 06/09/2005 | US20050124694 Using an amino acid compound ; eleimination of alcohol form body |
| 06/09/2005 | US20050124693 Biguanide derivative and therapeutic agent for diabetes containing the same |
| 06/09/2005 | US20050124691 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same |
| 06/09/2005 | US20050124690 Pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4-[2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro[2,5]octan-6-one |
| 06/09/2005 | US20050124689 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 06/09/2005 | US20050124688 Process for synthesizing d-tocotrienols from 2-vinylchromane compound |
| 06/09/2005 | US20050124687 Process for synthesizing d-tocotrienols |
| 06/09/2005 | US20050124686 Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases |
| 06/09/2005 | US20050124685 Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning |
| 06/09/2005 | US20050124684 5-(hydroxymethyl) furfural and derivatives as inhibitors of TNFalpha and IL-1beta production |
| 06/09/2005 | US20050124683 Viricides; immunomoderators |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124681 Prevention of warping by applying glue and clamping then curing and drying to form printed circuits using epoxy resins |
| 06/09/2005 | US20050124680 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 06/09/2005 | US20050124678 Transcription factor modulating compounds and methods of use thereof |
| 06/09/2005 | US20050124677 Peptide deformylase inhibitors |
| 06/09/2005 | US20050124676 EP4 receptor antagonists |
| 06/09/2005 | US20050124675 Indole compounds |
| 06/09/2005 | US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050124670 Novel arylazole derivatives, their manufacture and use as pharmaceutical agents |
| 06/09/2005 | US20050124669 for treating restless leg syndrome, epilepsy, smoking cessation, abstinence from addictive substances and dependencies, spasticity, muscle spasticity, hypotonia with paralysis, post herpetic neuralgia, chronic headache, lower back pain, surgical pain, etc.; i.e. 3-Amino-5,8-dimethyl-nonanoic acid |
| 06/09/2005 | US20050124667 Oxamide inhibitors of plasminogen activator inhibitor-1 |
| 06/09/2005 | US20050124665 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124664 Compounds for treatment of cardiovascular disorders using inhibitors of plasmnogen activator as anticoagulants for blood |
| 06/09/2005 | US20050124663 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 06/09/2005 | US20050124660 Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds |
| 06/09/2005 | US20050124659 Haloalkyl- and piperidine-substituted benzimidazole-derivatives |
| 06/09/2005 | US20050124658 Decahydronaphtho[2,3-c]furan derivatives |
| 06/09/2005 | US20050124657 Administering aryl piperidine compound before surgery to treat gastrointestinal disorders and to relieve stress associated with surgery |
| 06/09/2005 | US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/09/2005 | US20050124655 Cyclization; solvent extraction; hydrolysis; phosphodiesterase (PDE IV) inhibitors |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124653 Prevention of cancer using chloroquinine compound; side effect reduction |
| 06/09/2005 | US20050124651 Solid pharmaceutical preparation |
| 06/09/2005 | US20050124649 Deazapurines and uses thereof |
| 06/09/2005 | US20050124648 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 06/09/2005 | US20050124647 For example, 4-hydroxy-1,1-di-(5',6'-methylendioxy-indol-2-yl)-butane; antitumor agents, particularly for treating mammary carcinoma and colon carcinoma |
| 06/09/2005 | US20050124646 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 06/09/2005 | US20050124645 Methods and compositions for increasing CD4lymphocyte immune responsiveness |
| 06/09/2005 | US20050124644 Inhalers used in the treatment of respiratory system disorders, such as chronic obstructive pulmonary disease and asthma |
| 06/09/2005 | US20050124643 Steroid 3-O-sulphamate derivatives as inhibitors of oestrone sulphatase |
| 06/09/2005 | US20050124642 (1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds |
| 06/09/2005 | US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |